Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Clinical trial NCT02824575 · TERMINATED

Trial details

NCT number: NCT02824575
Sponsor: Montefiore Medical Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Adenocarcinoma Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2016-07-01
Primary completion: 2021-12-27
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.